Jim Simons's position in Abbott Laboratories is currently worth $408 Million. That's 0.51% of their equity portfolio (27th largest holding). The first Abbott Laboratories trade was made in Q4 2013. Since then Jim Simons bought shares twelve more times and sold shares on nine occasions. The investor's estimated purchase price is $517 Million, resulting in a loss of 21%.